Evidence is the operating system
AI in Clinic
Dec0ded is the software that powers MoleCure's Functional Genomics Clinic. The 7 year project designing multiple Neural Network Machine Learning Models that work inteoperably with other large data sets of genetic data. The structure of our data has led to the world's first Functional Genomic clinic powered by AI.
For the first time in the history of healthcare, we have increased patient access to safe, affordable, evidence-based medicine. Treatment is now made available faster than any current healthcare models can deliver.
Implementing AI into clinic is removing bias decision making, cognitive errors and other harmful practices that continue to persist in current healthcare delivery models. AI excels in 3 domains where humans fail. One, humans judge other human as worthy based on, economic class, race, disability, substance abuse, intellect, ethnic cleansing has and always will continue. AI will treat the disease and not a patient based on their worth. AI can accumulate, assess and make decisions based of the the most recently made available data and will select the best decision based on data as opposed to a human who will make decisions with access to less information and carelessly make a choice to protect ego. The third action AI can do where humans fail, learn from their mistakes.
Disease identification
By mapping the human genome, researchers could pinpoint specific genes linked to various diseases, enabling earlier detection and potential treatment development based on individual genetic profiles.
Personalized Medicine
Access to genetic information allows for tailored medical approaches where treatments are chosen based on a patient's specific genetic makeup, leading to more effective therapies and reduced side effects. Cancer research advancement
Genetic counseling
Understanding genetic variations allows for better genetic counseling, informing individuals about their potential risk for inherited diseases.
Research Acceleration
The readily available human genome sequence has accelerated research in various fields like evolutionary biology, pharmacogenetic's & gene therapy. Ethical considerations: The project also highlighted the ethical implications of genetic information, prompting discussions about privacy, genetic discrimination, and informed consent.
Medicine needs AI that earns trust before it scales.
Our Mission
Our Mission
Our Mission
To empower individuals with personalized health insights derived from their complete genetic blueprint, enabling informed decisions about their health and well-being.
Our Vision
Our Mission
Our Mission
A world where precision medicine is the standard, where every person understands their genetic health landscape, and where preventive, personalized care replaces reactive treatment.
Our Values
Our Mission
Our Values
Scientific integrity, patient privacy, accessibility, transparency, and continuous innovation drive.
AI In Clinic
REPLACING THE "PRACTICE" IN MEDICINE WITH PRECISION
Implementing Whole Genome Sequence & AI into clinic is removing bias decision making, cognitive errors and other harmful practices that continue to persist in current healthcare delivery models.
Diagnostic Delivery Model
We integrate your personal Genome sequence into our Diagnostic Delivery Model to give you the power to diagnose your symptoms. As a result, patients void extended wait times & cost. Patients experience injury, permanant disability or death as a result of a mal adaptive health system.
sequence gen0me
ID BARCODE
therapetic agent
Danielle Stella, Founder & CEO
Danielle Stella is a visionary biotechnologist and entrepreneur pioneering functional genomics and AI-driven healthcare. With over 15 years of experience in genomic research and machine learning, she founded Molecure with a mission to replace guesswork in medicine with precision diagnostics powered by whole genome sequencing and artificial intelligence.
Her career has been marked by groundbreaking research in functional genomics and AI applications in clinical diagnostics. Danielle holds a Ph.D. in Computational Biology from Stanford University and has published over 50 peer-reviewed papers on functional genomics, precision medicine, and AI-driven diagnosis of neuropsychiatric and age-related disorders.
Beyond her technical expertise, Danielle is a fervent advocate for patient empowerment and precision medicine. She believes that everyone deserves access to their genetic information and the tools to make informed health decisions based on their unique biology.
Ph.D. in Computational Biology
Stanford University
50+ Peer-Reviewed Publications
Leading genomic medicine journals
15+ Years in Biotechnology
Research, development, and leadership
Contact Us
Featured Products
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.